Investing
Top Pre-Market Analyst Downgrades (AMLN, BIIB, CIEN, XOM, GFA, MXIM, BTU, SLT, SPWRA)
Published:
Last Updated:
These are some of the top pre-market downgrades and cautious calls we have seen from Wall Street analysts this Wednesday morning:
- Amylin Pharmaceuticals (AMLN) Cut to Sell at Canaccord Adams.
- Biogen Idec (BIIB) Started as Sell at Brean Murray.
- Ciena (CIEN) Cut to Underperform at Credit Suisse.
- Exxon Mobil (XOM) Cut to Neutral at UBS.
- Gafisa (GFA) Cut to Neutral at UBS.
- Maxim Integrated (MXIM) Cut to Equal Weight at Barclays.
- Peabody Energy (BTU) Cut to Market Perform at FBR.
- Sterlite Industries (SLT) Cut to Sell at Citigroup.
- Sunpower (SPWRA) Cut to Accumulate at ThinkEquity.
Jon C. Ogg
January 28, 2009
Travel Cards Are Getting Too Good To Ignore (sponsored)
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.